Remember these are general guidelines
The increasing prevalence of type 2 diabetes and obesity in Europe is increasing the demand for GLP-1 drugs
Meredith Manson, RN, BSN LeeAnn Mentzer APRN, CRNA Brittany Gowe, APRN, FNP - Noude Aesthetics 2112 Didonato Dr, Chester MD Retail hours: 10-2 (667)-358-0815 call or text www.NoudeAesthetics.com [email protected] Where energy + injectables blend to create beautiful, natural results Tox Bio-Stim Fillers Lasers Facials Microneedling Sculptra Morpheus8 Hair Removal Radiesse CO2 Medical Weight Loss Vaginal Rejuvenation Skincare Consultations IV Therapy SkinLab Acne Treatment PDGF and more
For patients requiring additional glycaemic control, the dose may be increased to the maximum licensed dose of 2 mg once weekly after at least four weeks at the 1 mg dose, as per the UK SmPC
GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE/ mice